title: Identification of intermediately virulent Rhodococcus equi isolates from pigs.
abstract: We recently reported the existence of Rhodococcus equi isolates with at least three virulence levels, isolated from AIDS patients: virulent R. equi having 15- to 17-kDa antigens that kills mice with 10(6) cells, intermediately virulent R. equi having a 20-kDa antigen that kills mice with 10(7) cells, and avirulent R. equi that does not kill mice with 10(8) cells or more (S. Takai, Y. Imai, N. Fukunaga, Y. Uchida, K. Kamisawa, Y. Sasaki, S. Tsubaki, and T. Sekizaki, J. Infect. Dis. 172:1306-1311, 1995). Virulent R. equi having the 15- to 17-kDa antigens has been isolated frequently from horses and their environment, but the source of intermediately virulent R. equi having the 20-kDa antigen is poorly understood. There are many reports of the isolation of R. equi from the lymph nodes of pigs with and without lesions resembling those of tuberculosis. Therefore, we analyzed antigens of R. equi isolates from the submaxillary lymph nodes of pigs by immunoblotting with monoclonal antibodies against these virulence-associated antigens. Immunoblots of whole-cell antigen preparations of R. equi pig isolates revealed the presence of the 20-kDa antigen in almost all the pig isolates studied, and these isolates were intermediately virulent for mice. We also demonstrated that the expression of the 20-kDa antigen and its pathogenicity in mice were associated strongly with the presence of five large, distinct plasmids of 70 to 95 kb; two of the five plasmids from pig isolates were the same sizes as those from human isolates. These results suggest that R. equi having the 20-kDa antigen exists in the submaxillary lymph nodes of pigs and that the source of infection in some human cases might be associated with pigs and their environment.
authors.affiliation: Department of Animal Hygiene, School of Veterinary Medicine and Animal Sciences, Kitasato University, Aomori, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Takai
authors.forename: N
authors.initials: N
authors.lastname: Fukunaga
authors.forename: S
authors.initials: S
authors.lastname: Ochiai
authors.forename: Y
authors.initials: Y
authors.lastname: Imai
authors.forename: Y
authors.initials: Y
authors.lastname: Sasaki
authors.forename: S
authors.initials: S
authors.lastname: Tsubaki
authors.forename: T
authors.initials: T
authors.lastname: Sekizaki
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000382:microbiology; D000193:Actinomycetales Infections / Q000150:complications / Q000382:microbiology / Q000662:veterinary; D000818:Animals; D000942:Antigens, Bacterial / Q000737:chemistry / Q000235:genetics; D004262:DNA Restriction Enzymes; D006736:Horses; D006801:Humans; D051379:Mice; D008970:Molecular Weight; D010957:Plasmids / Q000235:genetics / Q000302:isolation & purification; D016929:Rhodococcus equi / Q000276:immunology / Q000302:isolation & purification* / Q000472:pathogenicity*; D013552:Swine / Q000382:microbiology*; D013553:Swine Diseases / Q000382:microbiology; D014774:Virulence / Q000235:genetics / Q000276:immunology
chemical_list: D000942:Antigens, Bacterial; D004262:DNA Restriction Enzymes